Adaptimmune: The FDA Removed the Temporary Ban on the Trial with NY-ESOS PEAR T-Cell Therapy for Mixoid Round Cell Liposarcoma
November 14, 2016
0
The U.S. Food and Drug Administration (FDA) has removed the partial clinical hold it put on …